12 March 2026

New Partnership: Xpedite Diagnostics

Exciting news! 

We are proud to announce our new partnership with Xpedite Diagnostics. 

Xpedite is dedicated to transforming disease diagnostics by making molecular testing accessible at the point-of-care. Their proprietary SwiftX™ technology simplifies and accelerates DNA & RNA extraction with streamlined protocols, minimal equipment, and high-quality results in minutes. 

Xpedite’s solutions are designed to make nucleic acid extraction faster, simpler, and more accessible for researchers, clinicians, and diagnostic laboratories. 

Through this partnership, Goffin Molecular Technologies will bring these innovative sample preparation solutions to laboratories in our region. 

We look forward to working together to advance accessible and efficient molecular diagnostics. 

New partnership announcement by Goffin Molecular Technologies

Gerelateerde blogs

Proven performance for confident CFTR detection

New Partnership: Xpedite Diagnostics

Goffin at the 10th MD.be Scientific Meeting in Antwerp